HealthTech Startups
ZoeNCure Therapeutics Raises ₹20 Crore to Take Dual-Payload Cancer Drug Towards Trials
The Delhi startup's antibody-drug conjugate targets liver and gastrointestinal cancers; the Tyagi family office led the round.
The Delhi startup's antibody-drug conjugate targets liver and gastrointestinal cancers; the Tyagi family office led the round.
The Mumbai startup, founded by an oncologist and a radiologist, plans three centres by year-end and ten across India in the long run.
The Jaipur startup has done 8,000+ screenings, works in 20+ government PHCs in Rajasthan and targets one lakh screenings by FY27.
Wearables, medicine-delivery logistics and foundation-backed deals dominated the month, according to DHN's funding tracker.
Get breaking health news alerts instantly — no spam.
AI assistant for news & information only — not medical advice. Emergency? Call 108 / 112.